About us Contacts Drug interactions: 390 212
Drug search by name

Kaletra Oral Solution and Lamotrigine Chewable Tablet

Determining the interaction of Kaletra Oral Solution and Lamotrigine Chewable Tablet and the possibility of their joint administration.

Check result:
Kaletra Oral Solution <> Lamotrigine Chewable Tablet
Relevance: 05.01.2023 Reviewer: Shkutko P.M., M.D., in

In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.

Consumer:

Using lamoTRIgine in combination with lopinavir can decrease the lamoTRIgine levels in your body. This can cause loss of seizure control or changes in behavior. You may need a dose adjustment or special test if you take both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Professional:

ADJUST DOSE: Coadministration with lopinavir/ritonavir may decrease the serum concentrations of lamotrigine. The mechanism is increased clearance due to induction of lamotrigine glucuronidation in the liver. In a study with healthy subjects, lopinavir/ritonavir reduced lamotrigine serum concentrations by approximately half.

MANAGEMENT: When lamotrigine is added to existing therapy containing an enzyme-inducing agent without valproate, the initial dosage of lamotrigine should be 0.6 mg/kg/day in two divided doses (2 to 12 years of age) or 50 mg/day (older than 12 years of age) for the first 2 weeks. The initial dosage should be doubled for the next 2 weeks, then increased by 1.2 mg/kg/day or 100 mg/day every 1 to 2 weeks as needed and as tolerated. The usual maintenance dosage is 5 to 15 mg/kg/day (up to 400 mg/day) in children up to 12 years of age and 300 to 500 mg/day (400 mg/day for the treatment of bipolar disorder) in older patients. Patients should be advised to promptly notify their physician if they experience worsening of seizure control or increased adverse effects. A reevaluation of all antiepileptic agents in the regimen should be considered prior to making any changes. If the enzyme-inducing agent is discontinued, lamotrigine half-life will be prolonged and a dosage adjustment may be necessary. Prescribers should refer to the lamotrigine product labeling for complete dosing information.

References
  • Cerner Multum, Inc. "Australian Product Information." O 0
Kaletra Oral Solution

Generic Name: lopinavir / ritonavir

Brand name: Kaletra

Synonyms: Kaletra

Lamotrigine Chewable Tablet

Generic Name: lamotrigine

Brand name: Lamictal, Lamictal ODT, Lamictal XR, Subvenite, Lamictal CD, LaMICtal Starter Kit, LaMICtal ODT Patient Titration Kit, LaMICtal XR Patient Titration Kit, LamoTRIgine Starter Kit, Subvenite Starter Kit, Lamictal, Lamictal ODT, Lamictal XR

Synonyms: LamoTRIgine, Lamotrigine

In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.